A detailed history of Nan Fung Group Holdings LTD transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Nan Fung Group Holdings LTD holds 368,665 shares of HRMY stock, worth $14.4 Million. This represents 12.94% of its overall portfolio holdings.

Number of Shares
368,665
Previous 368,665 -0.0%
Holding current value
$14.4 Million
Previous $12.4 Million 10.15%
% of portfolio
12.94%
Previous 12.24%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$45.4 - $60.91 $6.46 Million - $8.67 Million
-142,313 Reduced 27.85%
368,665 $20.3 Million
Q3 2022

Nov 10, 2022

SELL
$42.06 - $55.45 $5.26 Million - $6.93 Million
-125,000 Reduced 19.65%
510,978 $22.6 Million
Q2 2022

Aug 12, 2022

SELL
$33.54 - $52.15 $4.45 Million - $6.92 Million
-132,730 Reduced 17.27%
635,978 $31 Million
Q2 2021

Sep 22, 2021

BUY
$25.96 - $33.44 $20 Million - $25.7 Million
768,708 New
768,708 $21.7 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.31B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Nan Fung Group Holdings LTD Portfolio

Follow Nan Fung Group Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nan Fung Group Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nan Fung Group Holdings LTD with notifications on news.